Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
NXGL · NASDAQ · Surgical & Medical Instruments & Apparatus
Nexgel (NXGL) · oqro.io/stocks/NXGL · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$3.88+0.09 (+2.37%)
Close of Nov 13, 2026, vs Nov 12 · end-of-day, not a live quote
29 routine filings (option exercises, shares withheld for taxes, grants, gifts) are not listed here. Show them
Insider buying
Largest insider buy since 2021Traded Nov 10 · filed 4 days later
Since the trade +8.4% · S&P 500 +0.6% · to Nov 13
The CEO of Nexgel paid $733K out of pocket for Nexgel shares. 1 other person at Nexgel bought some too, in the same month. It was the first purchase in over a year.
Insider buying
Bought outside the usual windowTraded Nov 10 · filed 4 days later
Since the trade +8.4% · S&P 500 +0.6% · to Nov 13
A Nexgel director paid $25K out of pocket for Nexgel shares. 1 other person at Nexgel bought some too, in the same month. It was the first purchase in 24 months.
Traded Jun 18 – Jun 23, 2026 · largest single transaction ~$3.6KNot reported under a pre-arranged trading plan
Jun 18, 2026~$3.6K · 6,000 sh @ $0.5921
Insider selling
Traded Jun 11 · filed 4 days laterNot reported under a pre-arranged trading plan
Since the trade −67.1% · S&P 500 +2.3% · to Nov 13
The CEO of Nexgel sold $1.8K of Nexgel shares. The filing does not indicate a pre-arranged trading plan.
Traded Jun 4 – Jun 8, 2026 · largest single transaction ~$1.8KNot reported under a pre-arranged trading plan
Jun 4, 2026~$1.8K · 3,000 sh @ $0.5936
DetailsInsider selling
Traded Jun 1 · filed 2 days laterNot reported under a pre-arranged trading plan
Since the trade −67.3% · S&P 500 −0.6% · to Nov 13
The CEO of Nexgel sold $1.2K of Nexgel shares. The filing does not indicate a pre-arranged trading plan.
Traded May 27 – May 29, 2026 · largest single transaction ~$4.2KNot reported under a pre-arranged trading plan
May 27, 2026~$1.8K · 3,000 sh @ $0.5975
DetailsTraded Dec 22 – Dec 24, 2025 · largest single transaction ~$9.7KNot reported under a pre-arranged trading plan
Dec 22, 2025~$9.7K · 6,000 sh @ $1.61
DetailsAdam R. Levy (Chief Executive Officer) sold ~$10K of Nexgel
Planned saleScott Robert Henry (Director) sold ~$18K of Nexgel
Planned saleInsider selling
Traded Aug 28, 2025 · filed 2 days laterNot reported under a pre-arranged trading plan
Since the trade −92.1% · S&P 500 +16.3% · to Nov 13
The CEO of Nexgel sold $9.9K of Nexgel shares. The filing does not indicate a pre-arranged trading plan.
Scott Robert Henry (Director) sold ~$7.7K of Nexgel
Planned saleTraded Jun 9 – Jun 11, 2025 · largest single transaction ~$4.8KNot reported under a pre-arranged trading plan
Jun 9, 2025~$4.7K · 2,000 sh @ $2.33
DetailsTraded May 30 – Jun 5, 2025 · largest single transaction ~$2.3KNot reported under a pre-arranged trading plan
Jun 4, 2025~$2.3K · 1,000 sh @ $2.29
DetailsInsider selling
Traded May 16, 2025 · filed 5 days laterNot reported under a pre-arranged trading plan
Since the trade −92.0% · S&P 500 +27.0% · to Nov 13
The CEO of Nexgel sold $2.6K of Nexgel shares. The filing does not indicate a pre-arranged trading plan.
Scott Robert Henry (Director) sold ~$8.1K of Nexgel
Planned saleScott Robert Henry (Director) sold ~$7.8K of Nexgel
Planned saleAdam R. Levy (Chief Executive Officer) sold ~$12K of Nexgel
Planned saleScott Robert Henry (Director) sold ~$8.6K of Nexgel
Planned saleAdam R. Levy (Chief Executive Officer) sold ~$13K of Nexgel
Planned saleScott Robert Henry (Director) sold ~$9.8K of Nexgel
Planned saleAdam R. Levy (Chief Executive Officer) sold ~$15K of Nexgel
Planned saleScott Robert Henry (Director) sold ~$10K of Nexgel
Planned saleAdam R. Levy (Chief Executive Officer) sold ~$16K of Nexgel
Planned saleScott Robert Henry (Director) sold ~$14K of Nexgel
Planned saleInsider buying
Traded Nov 20, 2024 · filed 2 days later
Since the trade −94.1% · S&P 500 +27.8% · to Nov 13
The CFO of Nexgel paid $48K out of pocket for Nexgel shares. 5 other people at Nexgel bought some too, in the same month. It was the first purchase in over a year.
Insider buying
Traded Nov 20, 2024 · filed 2 days later
Since the trade −94.1% · S&P 500 +27.8% · to Nov 13
A Nexgel director paid $25K out of pocket for Nexgel shares. 5 other people at Nexgel bought some too, in the same month. It was the first purchase in over a year.
Insider buying
Traded Nov 20, 2024 · filed 2 days later
Since the trade −94.1% · S&P 500 +27.8% · to Nov 13
The CEO of Nexgel paid $10K out of pocket for Nexgel shares. 5 other people at Nexgel bought some too, in the same month. It was the first purchase in over a year.
Insider buying
Traded Nov 20, 2024 · filed 2 days later
Since the trade −94.1% · S&P 500 +27.8% · to Nov 13
A Nexgel director paid $10K out of pocket for Nexgel shares. 5 other people at Nexgel bought some too, in the same month. It was the first purchase in over a year.
Insider buying
Traded Nov 20, 2024 · filed 2 days later
Since the trade −94.1% · S&P 500 +27.8% · to Nov 13
A Nexgel director paid $5K out of pocket for Nexgel shares. 5 other people at Nexgel bought some too, in the same month. It was the first purchase in over a year.
Insider buying
Traded Nov 20, 2024 · filed 2 days later
Since the trade −94.1% · S&P 500 +27.8% · to Nov 13
A Nexgel director paid $10K out of pocket for Nexgel shares. 5 other people at Nexgel bought some too, in the same month. It was the first purchase in over a year.
Jun 23, 2026~$3K · 5,000 sh @ $0.5933
DetailsOfficial recordJun 8, 2026~$1.6K · 3,000 sh @ $0.547
DetailsOfficial recordMay 28, 2026~$4.2K · 7,000 sh @ $0.6058
DetailsOfficial recordMay 29, 2026~$1.8K · 3,000 sh @ $0.6003
DetailsOfficial recordDec 24, 2025~$6.3K · 4,000 sh @ $1.57
DetailsOfficial recordJun 11, 2025~$4.8K · 2,000 sh @ $2.39
DetailsOfficial recordJun 5, 2025~$2.3K · 1,000 sh @ $2.32
DetailsOfficial recordMay 30, 2025~$2.2K · 1,000 sh @ $2.22
DetailsOfficial record2 open-market purchases and 22 open-market sales by insiders of NXGL between Apr 13, 2025 and today, placed against the company's last 4 earnings releases. The latest on file was filed Aug 17, 2026.
PurchaseSale30 days before a release30 days after
| Earnings release | 30 days before | On the day | 30 days after |
|---|---|---|---|
| Aug 17, 2026 | None | None | None |
| Nov 12, 2025 | 1 sale | None | None |
| Aug 12, 2025 | None | None | 1 sale |
| May 13, 2025 | 1 sale | None | 6 sales |
Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies